Medtronic, Inc. (NYSE:MDT)
CAPS Rating:
A medical technology Company alleviating pain, restoring health, and extending life for millions of people around the world.
A medical technology Company alleviating pain, restoring health, and extending life for millions of people around the world.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
Recs
MDT has (another) new management team. Insiders thought that this team would be a return to "boy George" days, but no dice. The new team has seen fit to add more VP's while sending a clear message that it will reduce headcount in U.S. while adding more outside of U.S. and telling the world that it is net adding, which indeed is true. Perhaps I'm too parochial in my perspective, but looks like we'll just see more of the same. The focus on real long-term innovation is lacking. And, by the way, I've seen the movie before where engineers run operations, and it doesn't usually work too well. Of course adding more VP's is an interesting notion - board better get into this, or it is just another wallowing giant, asking for the "Fools" to performs. Like any of Willy Shakespeare's Fools, we see behind the curtain, and also see the courtier's for the buckets of suet they are. This Dog won't hunt.